High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma

Clinical trial NCT00287924 · UNKNOWN

Trial details

NCT number: NCT00287924
Sponsor: Children's Cancer and Leukaemia Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2005-03-01
Primary completion: 2010-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.